Endocrinology, Vol 137, 1851-1859, Copyright © 1996 by Endocrine Society

ARTICLES

Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells

DD De Leon, C Terry, Y Asmerom and P Nissley
Loma Linda School of Medicine, California 92350, USA.

A previous observation that insulin-like growth factor II (IGF-II) inhibits the cellular uptake of a lysosomal enzyme by inhibiting binding to the IGF-II/mannose 6-phosphate receptor led to the proposal that, in a cell producing IGF-II, the routing of lysosomal enzymes might be altered. To test this hypothesis MCF-7 breast cancer cells were transfected with pRc/CMV vector only (CMV) or vector containing IGF-II complementary DNA encoding either mature (M-II) or precursor (P- II) IGF-II, and the routing of cathepsin D, a predominant lysosomal enzyme in this cell line, was examined. The concentration of IGF-II in media conditioned by P-II clones (11.2 +/- 4.3 micrograms/ml) was much higher than in media conditioned by M-II clones (1.3 +/- 1.5 micrograms/ml). Metabolic labeling experiments were performed with 10 mM mannose 6-phosphate present in the medium to block reuptake of lysosomal enzymes. Cell extracts (C) and media (M) were immuno- precipitated with a cathepsin D antiserum, and immunoprecipitates were analyzed by SDS-PAGE. The mean of the C/M ratio of cathepsin D for the seven P-II clones (1.60 +/- 0.13) was significantly lower than for the six CMV clones (3.47 +/- 0.48). Similar results were obtained when conditioned M and C were examined by immunoblotting after a 48-h incubation. The mean of the C/M ratio for the seven P-II clones (11.4 +/- 1.6) was significantly lower than for the six CMV clones (24.9 +/- 5.2). There was also a strong negative correlation between the ratio of intracellular cathepsin D to extracellular cathepsin D and relative cathepsin D synthesis (r = 0.843), consistent with increased cathepsin D production in cells overexpressing IGF-II. It is concluded that endogenous IGF-II modulates the routing of cathepsin D in MCF-7 cells.

This article has been cited by other articles:

				J.-S. Wang, F.-B. Wang, Q.-G. Zhang, Z.-Z. Shen, and Z.-M. Shao Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II Mol. Cancer Res., March 1, 2008; 6(3): 372 - 382. [Abstract] [Full Text] [PDF]

				J. L. Kreiling, J. C. Byrd, R. J. Deisz, I. F. Mizukami, R. F. Todd III, and R. G. MacDonald Binding of Urokinase-type Plasminogen Activator Receptor (uPAR) to the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor: CONTRASTING INTERACTIONS OF FULL-LENGTH AND SOLUBLE FORMS OF uPAR J. Biol. Chem., May 30, 2003; 278(23): 20628 - 20637. [Abstract] [Full Text] [PDF]

				M. GOTO and K. MIZUNASHI Calcitonin Stimulates Lysosomal Enzyme Release and Uptake in LLC-PK1 Cells J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1640 - 1648. [Abstract] [Full Text]